The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease
Article first published online: 4 MAR 2013
© 2013 Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics
Volume 37, Issue 9, pages 905–914, May 2013
How to Cite
Emilsson, L., Carlsson, R., Holmqvist, M., James, S. and Ludvigsson, J. F. (2013), The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease. Alimentary Pharmacology & Therapeutics, 37: 905–914. doi: 10.1111/apt.12271
- Issue published online: 3 APR 2013
- Article first published online: 4 MAR 2013
- Manuscript Accepted: 11 FEB 2013
- Manuscript Revised: 30 JAN 2013
- Manuscript Revised: 15 JAN 2013
- Manuscript Received: 17 DEC 2012
Table S1. Small-intestinal histopathology classifications – a comparison.
Table S2. Classification of myocardial infarction.
Table S3. Cardiovascular characteristics and in-patient complications in myocardial infarction.
Table S4. Patient characteristics in individuals undergoing angiography for any reason.
Table S5. Sensitivity analysis - angiography that is due to ischaemic heart disease, IHD, indication with no earlier CABG*, or PCI*.
Table S6. Angiographic findings and primary decision within sensitivity analysis.
Table S7. Angiographic findings and primary decision.
Table S8. Characteristics of coeliac disease patients with a diagnosis of any ischaemic disease* undergoing angiography ≤10 days prior to or ≤30 days after SWEDEHEART admission.
Appendix S1. Relevant ICD codes for ischaemic heart disease.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.